The US Patent and Trademark Office Proposes New Rules Targeting Continuation Practice and Terminal Disclaimers

被引：0
作者：
Holman, Christopher M. [1 ,2 ]
机构：
[1] Univ Missouri Kansas City, Sch Law, Law, Kansas City, MO 64110 USA
[2] George Mason Univ, Ctr Intellectual Property Innovat Policy C IP2, Antonin Scalia Law Sch, Fairfax, VA 22030 USA
来源：
BIOTECHNOLOGY LAW REPORT | 2024年 / 43卷 / 04期
关键词：
D O I：
10.1089/blr.2024.54783.cmh
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：187 / 200
页数：14
相关论文
共 10 条
[1]  
Bernstein Frank L., 2024, Squire Patton Boggs Global IP & Privacy Law Blog
[2]  
Egan Edward J., 2015, Working Paper #7, Touch or Center for Management of Intellectual Capital
[3]   Can patents deter innovation? The anticommons in biomedical research [J].
Heller, MA ;
Eisenberg, RS .
SCIENCE, 1998, 280 (5364) :698-701
[4]   Recent Developments at the Intersection of Pharma, Patents, and Antitrust Law [J].
Holman, Christopher M. .
BIOTECHNOLOGY LAW REPORT, 2023, 42 (06) :282-295
[5]   A 2023 Review of Legislation Aimed at Increasing Generic and Biosimilar Competition [J].
Holman, Christopher M. .
BIOTECHNOLOGY LAW REPORT, 2023, 42 (02) :68-83
[6]  
ipwatchdog, About us
[7]  
Lemley MA, 2004, BOSTON U LAW REV, V84, P63
[8]   FDA provides additional guidance on 30-month stays - Multiple 30-month stays still possible [J].
Marenberg, BJ .
BIOTECHNOLOGY LAW REPORT, 2005, 24 (01) :7-9
[9]  
McDermott Eillen, 2024, IPWatchDog
[10]  
Patent Public Advisory Committee, 2023, Fee Setting Report
1